The FDA has sharply cut back on public advisory committee meetings, and this morning STAT’s Lizzy Lawrence explains what ...

PeaceHealth's move to replace ER doctors with ApolloMD clinicians is testing a new state law limiting corporate medicine.

With the drop in overdose deaths, “we're celebrating: a death toll that exceeds total American combat fatalities in Vietnam, ...

The FDA is cutting back on public advisory committee meetings, even as the public and other stakeholders seek more transparency.

Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

Vertex said a drug it secured as part of a $4.9 billion acquisition successfully reduced by half a key marker of a kidney disease known as IgA nephropathy.

Xenon Pharmaceuticals said its treatment for a common type of seizure disorder significantly reduced the frequency of those seizures compared to a placebo.

How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.

Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug Wegovy.

There is growing concern that the FDA is shunning advisory committees that allow agency leaders, drugmakers, patients, and doctors to speak their minds in public ...

A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.

Fresh turmoil at the FDA with Prasad’s exit. Vinay Prasad is out at the Food and Drug Administration for the second time during the Trump administration, after a tumultuous reig ...